No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Apixaban does not significantly prevent recurrent stroke after cryptogenic stroke in patients with atrial cardiopathy

byMinjee Kim

February 27, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in JAMA.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Adjunctive prednisolone does not reduce coronary artery lesions in Kawasaki disease

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Higher quantity of rib fractures may be a risk factor for venous thromboembolism

RelatedReports

Differences in sudden unexpected infant death rates reported between states

Cardiology

Adjunctive prednisolone does not reduce coronary artery lesions in Kawasaki disease

April 15, 2026

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization

Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]

Pharma

Apixaban reduces bleeding risk versus rivaroxaban in acute venous thromboembolism

March 23, 2026

$Bisphosphonate use and risk of atypical femur fractures$

Use of direct oral anticoagulants should not delay surgical intervention for patients with hip fractures

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Early de-escalation from intravenous to oral antibiotics may be appropriate for uncomplicated gram-negative bacteremia

Dental procedures not associated with increased periprosthetic joint infections for knee arthroplasty

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result